Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.

[1]  Jodie L Babitt,et al.  Ironing out the cross talk between FGF23 and inflammation. , 2017, American journal of physiology. Renal physiology.

[2]  Leah R. Padgett,et al.  Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women. , 2016, Bone.

[3]  K. White,et al.  Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice , 2016, PLoS biology.

[4]  J. Cauley,et al.  Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older Individuals , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  I. Macdougall,et al.  Iron deficiency anaemia , 2016, The Lancet.

[6]  A. Prentice,et al.  The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism , 2016, Bone.

[7]  D. Chappard,et al.  Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss , 2016, PloS one.

[8]  M. Wolf,et al.  Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production , 2015, Kidney international.

[9]  H. Boeing,et al.  Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study , 2015, PloS one.

[10]  D. Kotzot,et al.  Iron Supplementation Associated With Loss of Phenotype in Autosomal Dominant Hypophosphatemic Rickets. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  J. Chudek,et al.  Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly , 2015, Clinical endocrinology.

[12]  J. Chudek,et al.  Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population? , 2015, Clinical biochemistry.

[13]  M. Wolf,et al.  Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease , 2014, Current opinion in nephrology and hypertension.

[14]  E. Barrett-Connor,et al.  Serum estradiol associates with blood hemoglobin in elderly men: the MrOS Sweden study. , 2014, The Journal of clinical endocrinology and metabolism.

[15]  Leah R. Padgett,et al.  Iron and fibroblast growth factor 23 in X-linked hypophosphatemia. , 2014, Bone.

[16]  E. Farrow,et al.  Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  A. Prentice,et al.  Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children , 2013, Endocrine connections.

[18]  J. Cauley,et al.  Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: The Osteoporotic Fractures in Men (MrOS) study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  C. Behre,et al.  Low 25-OH vitamin D is associated with benign prostatic hyperplasia. , 2013, The Journal of urology.

[20]  B. Kestenbaum,et al.  Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. , 2013, The Journal of clinical endocrinology and metabolism.

[21]  Youjia Xu,et al.  Iron Overload Inhibits Osteoblast Biological Activity Through Oxidative Stress , 2013, Biological Trace Element Research.

[22]  U. Derici,et al.  The effects of iron on FGF23-mediated Ca–P metabolism in CKD patients , 2013, Clinical and Experimental Nephrology.

[23]  N. Bhattacharyya,et al.  Fibroblast growth factor 23: state of the field and future directions , 2012, Trends in Endocrinology & Metabolism.

[24]  A. Prentice,et al.  FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study , 2012, International Journal of Pediatric Endocrinology.

[25]  J. Muñoz-Castañeda,et al.  Calcium deficiency reduces circulating levels of FGF23. , 2012, Journal of the American Society of Nephrology : JASN.

[26]  J. Kanis,et al.  High serum adiponectin predicts incident fractures in elderly men: Osteoporotic fractures in men (MrOS) Sweden , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  A. Prentice,et al.  Iron status and fibroblast growth factor-23 in Gambian children , 2012, Bone.

[28]  M. Cho,et al.  Mechanism of FGF23 processing in fibrous dysplasia , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  D. Moran,et al.  Anemia, Iron Deficiency, and Stress Fractures in Female Combatants During 16 Months , 2011, Journal of strength and conditioning research.

[30]  R. Evstatiev,et al.  Iron sensing and signalling , 2011, Gut.

[31]  E. Farrow,et al.  Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice , 2011, Proceedings of the National Academy of Sciences.

[32]  Leah R. Padgett,et al.  Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. , 2011, The Journal of clinical endocrinology and metabolism.

[33]  D. Mellström,et al.  Serum fibroblast growth factor‐23 (FGF‐23) and fracture risk in elderly men , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  D. Mellström,et al.  Prevalence of Primary Hyperparathyroidism and Impact on Bone Mineral Density in Elderly Men: MrOs Sweden , 2011, World Journal of Surgery.

[35]  K. Michaëlsson,et al.  Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[36]  M. Uehara,et al.  Severe iron deficiency decreases both bone formation and bone resorption in rats. , 2009, The Journal of nutrition.

[37]  B. Clarke.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2009 .

[38]  B. Clarke,et al.  Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro , 2009 .

[39]  D. Mellström,et al.  Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men , 2009, Osteoporosis International.

[40]  E. Weinberg.  Role of iron in osteoporosis. , 2008, Pediatric endocrinology reviews : PER.

[41]  D. Mellström,et al.  Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. , 2008, European journal of endocrinology.

[42]  P. Kulkarni,et al.  Anemia , 2007 .

[43]  T. Craig,et al.  Biological activity of FGF-23 fragments , 2007, Pflügers Archiv - European Journal of Physiology.

[44]  S. Ljungman,et al.  Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly , 2007, Journal of internal medicine.

[45]  R. Mason,et al.  Bone as a source of FGF23: regulation by phosphate? , 2004, Bone.

[46]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  H. Jüppner,et al.  Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. , 2003, Kidney international.

[48]  Y. Takeuchi,et al.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.

[49]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.